Prolactin levels, endothelial dysfunction, and the risk of cardiovascular events and mortality in patients with CKD.


BACKGROUND AND OBJECTIVES Both prolactin clearance and production are altered in CKD. In nonrenal populations, emerging evidence suggests that prolactin participates in the atherosclerotic process. Given the elevated cardiovascular risk of CKD, this study examined links between prolactinemia, vascular derangements, and outcomes. DESIGN, SETTING… (More)
DOI: 10.2215/CJN.06840711


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.